account_balance
Investment manager · 13F filer · SEC CIK 2013341
Foresite Capital Management VI LLC
Reported value$643Mas of Jun 30, 2026
Positions23 8 new, 2 sold out
Top 10 weight81.5%CGON alone is 26%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
CGONCG Oncology, Inc.
26.2%Added +7%
ALMSAlumis Inc.
18.6%
SPTXSeaport Therapeutics, Inc.
6.0%New
DNLIDenali Therapeutics Inc.
5.6%Added +15%
CLDXCelldex Therapeutics, Inc.
5.1%Added +178%
AGIOAgios Pharmaceuticals, Inc.
4.5%Added +50%
CRVSCorvus Pharmaceuticals, Inc.
4.3%
PBLSParabilis Medicines, Inc.
4.3%New
GHRSGH Research PLC
3.9%Added +198%
JBIOJade Biosciences, Inc.
3.1%Added +177%
HNGEHinge Health, Inc.
2.8%
KYMR2.6%CGONCG Oncology, Inc.
26.2%Added +7%
ALMSAlumis Inc.
18.6%
SPTX6.0%DNLI5.6%CLDX5.1%AGIO4.5%CRVS4.3%PBLS4.3%GHRS3.9%JBIO3.1%HNGE2.8%KYMR2.6%Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
CGON CG Oncology, Inc. 26.2% Added +7%ALMS Alumis Inc. 18.6% HeldSPTX Seaport Therapeutics, Inc. 6.0% NewDNLI Denali Therapeutics Inc. 5.6% Added +15%CLDX Celldex Therapeutics, Inc. 5.1% Added +178%AGIO Agios Pharmaceuticals, Inc. 4.5% Added +50%CRVS Corvus Pharmaceuticals, Inc. 4.3% HeldPBLS Parabilis Medicines, Inc. 4.3% NewGHRS GH Research PLC 3.9% Added +198%JBIO Jade Biosciences, Inc. 3.1% Added +177%HNGE Hinge Health, Inc. 2.8% HeldKYMR Kymera Therapeutics, Inc. 2.6% Held
What changed